amoxicillin

(redirected from Moxatag)
Also found in: Thesaurus, Medical.
Related to Moxatag: Dispermox

a·mox·i·cil·lin

 (ə-mŏk′sĭ-sĭl′ĭn)
n.
A semisynthetic penicillin, C16H19N3O5S, having an antibacterial spectrum of action similar to that of ampicillin.

[am(ino)- + (hydr)ox(y) + (pen)icillin.]

amoxicillin

(əˈmɒksɪˌsɪlɪn) or

amoxycillin

n
a penicillin antibiotic used to treat a wide range of bacterial infections

am•ox•i•cil•lin

(æmˌɒk səˈsɪl ɪn, əˌmɒk-)

n.
a semisynthetic penicillin, C18H19N3O5S, taken orally as a broad-spectrum antibiotic.
[1970–75; perhaps am(ino-hydr)ox(yphenyl) + (pen) icillin]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.amoxicillin - an antibioticamoxicillin - an antibiotic; a semisynthetic oral penicillin (trade names Amoxil and Larotid and Polymox and Trimox and Augmentin) used to treat bacterial infections
penicillin - any of various antibiotics obtained from Penicillium molds (or produced synthetically) and used in the treatment of various infections and diseases
Translations
amoxicilin

amoxicillin

n amoxicilina
References in periodicals archive ?
rights to Moxatag (amoxicillin extended-release tablets) from Pragma Pharmaceuticals LLC.
Vernalis plc has purchased antibiotic Moxatag's US rights from Pragma Pharmaceuticals, LLC (Pragma).
UK-based drugmaker Vernalis plc (LSE: VER) has acquired US rights to Moxatag (amoxicillin extended-release tablets) from Pragma Pharmaceuticals, LLC (Pragma), the company's US-based commercialisation arm, Vernalis Therapeutics Inc., said.
M2 EQUITYBITES-October 6, 2015-Pragma Pharmaceuticals' US rights for Moxatag amoxicillin acquired by Vernalis
M2 PHARMA-October 6, 2015-Pragma Pharmaceuticals' US rights for Moxatag amoxicillin acquired by Vernalis
The drug chosen, amoxicillin (Amoxil, Dispermox, Moxatag, Trimox), is the antibiotic most commonly prescribed for this disorder.
MiddleBrook Pharmaceuticals has retained Almac Pharma Services to provide packaging services for physician samples of Moxatag (amoxicillin extended-release) Tablets.
(Germantown, MD), a pharmaceutical company focused on developing and commercializing novel anti-infective products, said that three patents protecting Moxatag (amoxicillin extended-release) Tablets, 775mg, were listed in the FDA Orange Book on Oct.
Moxatag, a member of the penicillin class of antibacterials, is approved for use in adults and in children [greater than or equal to] 12 years of age.
(amoxicillin extended-release tablets, MiddleBrook Pharmaceuticals Inc.) The FDA also approved once-dally Moxatag tablets 775 mg for treatment of patients aged 12 years and older with pharyngitis and/or tonsillitis secondary to Streptococcus pyogenes infection.
The FDA also approved once-daily Moxatag tablets 775 mg for treatment of patients aged 12 years and older with pharyngitis and/or tonsillitis secondary to Streptococcus pyogenes infection.
The FDA also approved once-daily Moxatag (amoxicillin extended-release) tablets 775 mg for treatment of patients aged 12 years and older with pharyngitis and/or tonsillitis secondary to Streptococcus pyogenes infection.